Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab.
Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab.
Journal: Journal of clinical medicine
Published: December 19, 2017
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC.
Journal: Cancer immunology research
Published: December 05, 2016
A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma.
Journal: Investigational new drugs
Published: February 17, 2016
Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma.
Journal: American journal of clinical oncology
Published: January 24, 2015
Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 01, 2014
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.
Journal: Lancet (London, England)
Published: July 19, 2014
BRAF-Targeted Therapy to Treat Superior Vena Cava Syndrome in a Patient With Metastatic Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 09, 2014
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
Journal: The New England journal of medicine
Published: June 04, 2013
Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer.
Journal: Cancer chemotherapy and pharmacology
Published: February 27, 2011
Ipilimumab: unleashing the power of the immune system through CTLA-4 blockade.
Journal: Seminars in oncology
Published: November 16, 2010
Last Updated: 09/26/2026